US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 1, 2017 (9 years ago)

Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP)…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.

What was recalled

Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.

Recalling firm
Allergan Sales, LLC
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0929-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Prednisolone recalls

See all